【24h】

Innate-Type and Acquired-Type Allergy Regulated by IL-33

机译:IL-33调节的先天性和后天性过敏

获取原文
           

摘要

ABSTRACT We propose two types of allergic response: IgE-dependent and IgE-independent, and designate these as 'acquired-type allergy' and 'innate-type allergy', respectively. IL-33 stimulates both innate (basophils, mast cells, or group 2 innate lymphoid cells) and acquired (Th2 cells) allergy-related cells to induce and/or augment Th2 cytokine production, which leads to eosinophilic inflammation in vivo . Thus, IL-33 is an essential regulator for both 'innate-type allergy' and 'acquired-type allergy', and might be an attractive therapeutic target for allergic diseases.
机译:摘要我们提出两种类型的过敏反应:IgE依赖性和IgE依赖性,分别将其指定为“后天性过敏”和“先天性过敏”。 IL-33刺激先天性(嗜碱性粒细胞,肥大细胞或第2组先天性淋巴样细胞)和后天性(Th2细胞)过敏相关细胞诱导和/或增加Th2细胞因子的产生,从而导致体内嗜酸性粒细胞炎症。因此,IL-33是“先天性过敏”和“后天性过敏”的重要调节剂,并且可能是过敏性疾病的诱人治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号